Cogent Biosciences, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
COGT on Nasdaq
Industry
Pharmaceutical Preparations
Location
275 Wyman Street, 3 Rd Floor, Waltham, Massachusetts

There are no Buy or Sell transactions made by insiders since 7/8/2023

Cogent Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fairmount Funds Management LLC Director $46.7 M Jun 10, 2024
Cole Pinnow Chief Commercial Officer $5.25 K May 25, 2024
Arlene Morris Director Jun 5, 2024
Todd Shegog Director Jun 5, 2024
Matthew Ros Director Jun 5, 2024
Peter Evan Harwin Director Jun 5, 2024
Karen Jean Ferrante Director Jul 1, 2024
Jessica Sachs Chief Medical Officer Jan 23, 2024
John Edward Robinson Chief Scientific Officer Jan 23, 2024
Evan Kearns Chief Legal Officer Jan 23, 2024
John L. Green Chief Financial Officer Jan 23, 2024
Christopher W. Cain Director Jun 5, 2024
Andrew R. Robbins President and CEO, Director Jan 23, 2024

Recent Insider Transactions by Companies or Individuals for Cogent Biosciences, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership